Reduction of reinfarction and angina with use of low-molecular-weight heparin therapy after streptokinase (and heparin) in acute myocardial infarction
- 1 June 1996
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 77 (14), 1145-1148
- https://doi.org/10.1016/s0002-9149(96)00152-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.Circulation, 1994
- Reactivation of Unstable Angina after the Discontinuation of HeparinNew England Journal of Medicine, 1992
- Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.Circulation, 1992
- Low molecular weight heparinBlood, 1992
- Effect of coronary reocclusion after initial reperfusion on ventricular function and infarct sizeJournal of the American College of Cardiology, 1991
- Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.Circulation, 1990
- Guidelines for the early management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction)Journal of the American College of Cardiology, 1990
- Platelets and Thrombolytic TherapyNew England Journal of Medicine, 1990
- Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: Influence of infarct location on arterial patency, left ventricular function and mortalityJournal of the American College of Cardiology, 1989
- The ischemic risk syndrome following thrombolysisCurrent Opinion in Cardiology, 1988